← Evidence map

ArticleDementia and geriatric cognitive disorders extra

Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study.

Hossein Pakdaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
pooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28626468